Clinical Trials Directory

Trials / Conditions / Stage III Malignant Testicular Germ Cell Tumor

Stage III Malignant Testicular Germ Cell Tumor

10 registered clinical trials studyying Stage III Malignant Testicular Germ Cell Tumor.

StatusTrialSponsorPhase
WithdrawnMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant
NCT01558778
Roswell Park Cancer InstituteN/A
TerminatedDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
NCT01159067
City of Hope Medical CenterPhase 2
CompletedPhase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer
NCT01037790
Abramson Cancer Center at Penn MedicinePhase 2
CompletedOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
NCT00795769
Fred Hutchinson Cancer CenterPhase 2
CompletedLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem
NCT00408681
Fred Hutchinson Cancer CenterN/A
CompletedSurgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors
NCT00053352
Children's Oncology GroupPhase 3
CompletedIpilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer
NCT00060372
National Cancer Institute (NCI)Phase 1
TerminatedImatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testic
NCT00042952
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1